FDA Hearing on Intrinsa
On December 2, 2004, the FDA Reproductive Health Advisory Committee convened to consider the first drug for "female sexual dysfunction." The New View Campaign opposed the approval of this drug, and prepared factsheets and invited speakers to the hearing. These resources offer a template for every similar drug application to come down the line, and provide a rich introduction to New View positions.
New View Resources*
Leonore Tiefer's Written Statement for FDA Hearing Dec.
Factsheet on Problems
with Clinical Trials
The entire background materials and transcript of Dec. 2 can be downloaded
*The New View documents on this page are PDF files and must be opened with Adobe Acrobat. For a free download, click here.